Drug Strategies
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2012 | 408,544 | 378,341 | 30,203 | 36.0 | 33% |
| 2013 | 429,427 | 333,290 | 96,137 | 44.5 | 33% |
| 2014 | 319,850 | 366,179 | −46,329 | 42.0 | 48% |
| 2015 | 250,400 | 310,782 | −60,382 | 49.2 | 38% |
| 2016 | 203,125 | 306,082 | −102,957 | 41.7 | 22% |
| 2017 | 276,266 | 308,019 | −31,753 | 41.6 | 18% |
| 2018 | 256,711 | 318,984 | −62,273 | 38.9 | 22% |
| 2019 | 156,286 | 360,700 | −204,414 | 27.6 | 32% |
| 2020 | 192,630 | 312,252 | −119,622 | 27.9 | 48% |
| 2021 | 118,239 | 284,473 | −166,234 | 31.9 | 36% |
| 2022 | 182,093 | 284,100 | −102,007 | 18.2 | 37% |
| 2023 | 73,344 | 237,590 | −164,246 | 17.7 | 45% |
| 2024 | 1,867,462 | 375,191 | 1,492,271 | 60.4 | 35% |
In its most recent public year (2024), this organization brought in $1,492,271 more than it spent. Its reserves stood at about 60.4 months of spending, up from 36 in 2012. Staff pay was 35% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2024. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Drug Strategies's IRS filings as a feed — one entry per filing year, through 2024. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works